References and Research Abstracts Supporting Relax and Calm
1. Facts & Statistics. (n.d.). http://www.adaa.org/aboutadaa/press-room/facts-statistics
2. Chong Y, Fryar C, Gu Q. (2013). Prescription Sleep Aid Use Among Adults: United States, 2005–2010. Data Brief No. 127 U.S. Department of Health and Human Services Center For Disease Control and Prevention National Center for Health Statistics.
3. Kessler, Ronald C. et al. “Insomnia and the Performance of US Workers: Results from the America Insomnia Survey.” Sleep 34.9 (2011): 1161–1171.PMC. Web. 7 Sept. 2015.
4. Juneja, L. R., Chu, D. C., Okubo, T., Nagato, Y., & Yokogoshi, H. (1999). L-theanine—a unique amino acid of green tea and its relaxation effect in humans. Trends in Food Science & Technology, 10(6), 199-204.
5. Lu, K., Gray, M. A., Oliver, C., Liley, D. T., Harrison, B. J., Bartholomeusz, C. F., ... & Nathan, P. J. (2004). The acute effects of L-theanine in comparison with alprazolam on anticipatory anxiety in humans. Human Psychopharmacology: Clinical and Experimental, 19(7), 457-465.
6. Kimura, K., Ozeki, M., Juneja, L. R., & Ohira, H. (2007). L-Theanine reduces psychological and physiological stress responses. Biological psychology, 74(1), 39-45.
7. Kakuda, T., Nozawa, A., Sugimoto, A., Nino, H., 2002. Inhibition by theanine of binding of [3H]AMPA, [3H] Kainate, and [3H]MDL 105,519 to glutamate receptors. Bioscience, Biotechnology, and Biochemistry 66, 2683– 2686.
8. Gyllenhaal C, Merritt SL, Peterson SD, Block KL, Gochenour T. Efficacy and safety of herbal stimulants and sedatives in sleep disorders. Sleep Med Rev 2000;4:229-51.
9. Meoli AL, Rosen C, Kristo D, et al. Oral nonprescription treatment for insomnia: An evaluation of products with limited evidence. J Clin Sleep Med 2005;1:173-87.
10. Stevenson C, Ernst E. Valerian for insomnia : A systematic review of randomized clinical trials. Sleep Med 2000;1:91-9.
11. Hallam KT, Olver JS, McGrath C, Norman TR. Comparative cognitive and psychomotor effects of single doses of valeriana officianalis and triazolam in healthy volunteers. Hum Psychopharmacol 2003;18:619- 25.
12. Maroo, N., Hazra, A., & Das, T. (2013). Efficacy and safety of a polyherbal sedative-hypnotic formulation NSF-3 in primary insomnia in comparison to zolpidem: a randomized controlled trial. Indian journal of pharmacology, 45(1), 34.
13. Morin, C. M., Koetter, U., Bastien, C., Ware, J. C., & Wooten, V. (2005). Valerian-hops combination and diphenhydramine for treating insomnia: a randomized placebo-controlled clinical trial. SLEEP-NEW YORK THEN WESTCHESTER-, 28(11), 1465.
14. Lindberg JS, Zobitz MM, Poindexter JR, Pak CY. Magnesium bioavailability from magnesium citrate and magnesium oxide. J Am Coll Nutr. 1990 Feb;9(1):48-55.
15. Walker AF, Marakis G, Christie S, Byng M. Mg citrate found more bioavailable than other Mg preparations in a randomised, double-blind study. Magnes Res. 2003 Sep;16(3):183-91.
References and Research Abstracts Supporting Triple-Mag
1. “Nutrient Intakes Percent of population 2 years old and over with adequate intakes based on average requirement”. Community Nutrition Mapping Project. 2009-07-29. Retrieved 2012-02-11.
2. Nielsen, F.H., Milne, D.B., Klevay, L.M., Gallagher, S., Johnson, L.K. 2007. Dietary magnesium defi ciency induces heart rhythm changes, impairs glucose tolerance, and decreases serum cholesterol in post menopausal women. Journal of the American College of Nutrition. 26(2):121-132.
3. The Magnesium Miracle, by Carolyn Dean, M.D., N.D., Ballantine Books, 2007.
4. 1992: Seelig MS, Altura BT, Resnick LM, Handwerker SM, Altura BM: Low magnesium, a common denominator in pathologic processes in diabetes mellitus, cardiovascular disease, and eclampsia. J Am Coll Nutr 11:608.
5. G Moorkens, B Manuel y Keenoy, J Vertommen, S Meludu, M Noe, I De Leeuw. Magnesium defi cit in a sample of the Belgian population presenting with chronic fatigue. Magnes Res. 1997 Dec;10(4):329- 37. PMID: 9513929
6. J Eisinger, A Plantamura, P A Marie, T Ayavou. Selenium and magnesium status in fi bromyalgia. Magnes Res. 1994 Dec;7(3- 4):285-8. PMID: 77866927. 1995: Seelig MS: Prenatal and genetic magnesium defi ciency in cardiomyopathy; possible vitamin and trace mineral interactions. In “Pediatric Nutrition XXII”, Ed F Lifshitz, CRC Press, Boca Raton, FL, pp 197-224.
7. Martha Rodríguez-Morán, Fernando Guerrero-Romero. Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized doubleblind controlled trial. Diabetes Care. 2003 Apr;26(4):1147-52. PMID: 12663588
8. F Facchinetti, P Borella, G Sances, L Fioroni, R E Nappi, A R Genazzani. Oral magnesium successfully relieves premenstrual mood changes. Obstet Gynecol. 1991 Aug;78(2):177-81. PMID: 20677599. 1995: Seelig MS: Calcium and magnesium deposits in disease, with emphasis on arteriosclerosis, in Ed. G Berthon “Handbook on Metal-Ligand Interactions in Biological Fluids” vol 2 (Part 4): Chapt 5, Dekker, N.Y., N.Y., pp 914-934.
9. Afshin Samaie, Nabiollah Asghari, Raheb Ghorbani, Jafar Arda. Blood Magnesium levels in migraineurs within and between the headache attacks: a case control study. Pan Afr Med J. 2012 ;11:46. Epub 2012 Mar 15. PMID: 22593782
10. 1996: Seelig MS & Elin RJ: Is there a place for magnesium in the treatment of acute myocardial infarction? Am Heart J 132 (Part 2):471-477.
11. 1996: Antman EM, Seelig MS, Fleischmann K, Lau J, Kuntz K, Berkey CS, McIntosh M: Editorial. Magnesium in acute myocardial infarction: scientifi c, statistical, and economic rationale for its use. Cardiovasc Drugs & Therapy 10:297-301.
12. 1997: Seelig MS, Altura BM: Editorial. How best to determine magnesium requirement: need to consider cardiotherapeutic drugs that affect its retention. J Am Coll Nutr 16:2-4.
13. Zemel, P.C., Zemel, M.B., Urberg, M., Douglas, F.L., Geiser, R. & Sowers, J.R. (1990): Metabolic and hemodynamic effects of magnesium supplementation in patients with essential hypertension. Am. J. Clin. Nutr. 51, 665-669.
14. 1990: Seelig MS: Increased magnesium need with use of combined estrogen and calcium for osteoporosis treatment. Magnesium Res 3:197-215.
15. 1998: Seelig MS: Review and hypothesis: might patients with the chronic fatigue syndrome have latent tetany of magnesium defi ciency. J Chron Fatigue Syndr 4:77-108.
16. Clin Gastroenterol Hepatol. 2013 Dec 13. pii: S1542- 3565(13)01893-4. doi: 10.1016/j.cgh.2013.12.005 PMID: 24342746
17. Massachusetts Institute Of Technology. “MIT: Magnesium May Reverse Middle-age Memory Loss.” ScienceDaily. ScienceDaily, 27 December 2004. .